Differential expression of CCR8 in tumors versus normal tissue allows specific depletion of tumor-infiltrating T regulatory cells by GS-1811, a novel Fc-optimized anti-CCR8 antibody.
Saved in:
| Title: | Differential expression of CCR8 in tumors versus normal tissue allows specific depletion of tumor-infiltrating T regulatory cells by GS-1811, a novel Fc-optimized anti-CCR8 antibody. |
|---|---|
| Authors: | Weaver, Jessica D.1, Stack, Edward C.1, Buggé, Joshua A.1, Changyun Hu1, McGrath, Lara1, Mueller, Amy1, Wong, Masie1, Klebanov, Boris1, Rahman, Tanzila1, Kaufman, Rosemary1, Fregeau, Christine1, Spaulding, Vikki1, Priess, Michelle1, Legendre, Kristen1, Jaffe, Sarah1, Upadhyay, Dhruvkumar1, Singh, Anirudh1, Chang-Ai Xu1, Krukenberg, Kristin1, Yan Zhang1 |
| Source: | OncoImmunology. 2022, Vol. 11 Issue 1, p1-16. 16p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
